Relative value units (RVUs) were devised to provide a common scale to judge the relative resources used to provide a service. The relative value of each service is reassessed periodically by the Relative Value Scale Update Committee and others to decide whether changes need to be made.
In a recent ‘Viewpoint’ paper (Nurok and Gewertz; JAMA, 2019) the authors make a powerful case that the use of RVUs as the only measure of physician performance is not only misplaced but leads to inferior patient care. The connection to financial compensation such as bonuses is especially fraught. The report that some organizations are moving away from RVU-based, fee-for-service reimbursement methods that alternative payment models that focus on quality rather than incentivize high volume care. They provide evidence that these non-RVU models can even reduce healthcare costs.
Aside from financial incentives, the authors also point out the moral reasons exist for moving away from RVU-based compensation models. A physician’s first duty should always be to the patient and not the payors. Furthermore, RVUs emphasize procedures while diminishing the role of public health and important physician-patient interactions, such as counseling.
In summary, RVUs should be just one part not the only party of individual clinician performance. One group created the all-in model consisting of
Please log in to access ObGFirst and the 2T US Atlas
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst